György Vereb

14PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Molecular imaging (incl. electron microscopy and neutron diffraction)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 27, 2025
Comparative Evaluation of Bleomycin- and Collagen-V-Induced Models of Systemic Sclerosis: Insights into Fibrosis and Autoimmunity for Translational Research.

Lőrinc Nagy, Gábor Nagy, Tamás Juhász

|Mar 13, 2025
Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.

Bence Gergely, Márk A Vereb, István Rebenku

|Mar 07, 2025
EGFR-HER2 Transactivation Viewed in Space and Time Through the Versatile Spectacles of Imaging Cytometry-Implications for Targeted Therapy.

László Ujlaky-Nagy, János Szöllősi, György Vereb

|Nov 27, 2024
Inhibition of K+ Channels Affects the Target Cell Killing Potential of CAR T Cells.

Ghofrane Medyouni, Orsolya Vörös, Vivien Jusztus

|Jun 19, 2024
Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.

László Ujlaky-Nagy, János Szöllősi, György Vereb

|Jun 28, 2023
CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells.

Marianna Mezősi-Csaplár, Árpád Szöőr, György Vereb

Pageof 3

Frequent Collaborators

1 joint publications

György Vámosi

1 joint publications

Tillmann Michels

1 joint publications

Klaus Griewank

1 joint publications

Christian H Wetzel